Vaccinex Announces Full Enrollment Achieved in Ongoing CLASSICAL-Lung Phase 1b/2 Trial of Pepinemab in Combination with BAVENCIO® (avelumab) in Advanced Non-Small Cell Lung Cancer

    NEXT STORY
    Global Pediatric Vaccine Market Will Reach to USD 56.28 Billion By 2025: Zion Market Research
    PREV STORY
    iTeos Therapeutics Announces Appointment of Matthew Call as Chief Operating Officer
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Novartis ernennt Elizabeth Barrett zur Chefin Onkologie

    Novartis ernennt eine erfahrene Pharma-Führungskraft mit starken Marketingfähigkeiten, um das Onkologiegeschäft weiter zu entwickeln ...

    author_avatar
    NASDAQ Market News

    Motif Bio REVIVE-2 Phase 3 Study Results with Iclaprim Published in Peer-reviewed Journal, Antimicrobial Agents and Chemotherapy

    author_avatar
    NASDAQ Market News

    New U.S. Patent Issuance Granted to AXIM® Biotechnologies for Oral Care Composition Containing Cannabinoids

    NEW YORK, Jan. 29, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (“AXIM® Biotech” or ...

    author_avatar
    NASDAQ Market News